|
Volumn 42, Issue 1, 2001, Pages 125-134
|
OPC-8212, a quinoline derivative, counteracts the reduction in type III collagen mRNA due to lipopolysaccharides in cultured rat cardiac fibroblasts
a a a a a a a a a a |
Author keywords
Cytokine; Extracellular matrix; Growth factor; Heart; Molecular biology
|
Indexed keywords
COLLAGEN TYPE 3;
LIPOPOLYSACCHARIDE;
MESSENGER RNA;
PIPERANOMETOZINE;
QUINOLONE DERIVATIVE;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL CELL;
ARTICLE;
CONTROLLED STUDY;
CULTURE MEDIUM;
CYTOKINE PRODUCTION;
DRUG EFFECT;
FIBROBLAST CULTURE;
HEART;
NEWBORN;
NONHUMAN;
NORTHERN BLOTTING;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
ANIMALS;
CARDIOTONIC AGENTS;
COLLAGEN;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FIBROBLASTS;
LIPOPOLYSACCHARIDES;
MYOCARDIAL CONTRACTION;
MYOCARDIUM;
QUINOLINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RNA, MESSENGER;
STIMULATION, CHEMICAL;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 17744385123
PISSN: 00214868
EISSN: None
Source Type: Journal
DOI: 10.1536/jhj.42.125 Document Type: Article |
Times cited : (3)
|
References (18)
|